Evidence map›Paper›PMID 40714912›Full record

ArticleCancer medicine2025

Factors Associated With Employment and Quality of Working Life in Patients With Metastatic Breast Cancer.

Alina Kias, Martina E Schmidt, Anouk E Hiensch, Dorothea Clauss, Evelyn M Monninkhof, Mireia Pelaez, Jon Belloso, Nadira Gunasekara, Maike G Sweegers, Mark Trevaskis and 13 more

Registry-linked trialAbstract readMulticenter Study
In one paragraph

Article in Cancer medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT04120298 (Effects of Structured and Individualized Exercise in Patients With Metastatic Breast Cancer on Fatigue and Quality of Life), which is not on this map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04120298 naactive not recruitingnot on this map

Effects of Structured and Individualized Exercise in Patients With Metastatic Breast Cancer on Fatigue and Quality of Life

TypeinterventionalSponsorUMC UtrechtRan2020 to 2027Enrolled357ConditionsMetastatic Breast CancerArmsSupervised exercise
3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

23 authors.

Alina KiasGerman Cancer Research Center (DKFZ) and National Center for Tumor Diseases (NCT) Heidelberg (a Partnership Between DKFZ and University Medical Center Heidelberg), Heidelberg, Germany.ORCID https://orcid.org/0000-0002-6201-5131
Martina E SchmidtGerman Cancer Research Center (DKFZ) and National Center for Tumor Diseases (NCT) Heidelberg (a Partnership Between DKFZ and University Medical Center Heidelberg), Heidelberg, Germany.ORCID https://orcid.org/0000-0002-2095-2426
Anouk E HienschJulius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht University, Utrecht, the Netherlands.ORCID https://orcid.org/0000-0002-6216-2609
Dorothea ClaussGerman Cancer Research Center (DKFZ) and National Center for Tumor Diseases (NCT) Heidelberg (a Partnership Between DKFZ and University Medical Center Heidelberg), Heidelberg, Germany.ORCID https://orcid.org/0009-0003-0752-5301
Evelyn M MonninkhofJulius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht University, Utrecht, the Netherlands.
Mireia PelaezGipuzkoa Cancer Unit, OSID-Onkologikoa, BioGipuzkoa, Osakidetza, San Sebastian, Spain.ORCID https://orcid.org/0000-0001-8022-4925
Jon BellosoGipuzkoa Cancer Unit, OSID-Onkologikoa, BioGipuzkoa, Osakidetza, San Sebastian, Spain.
Nadira GunasekaraGerman Sport University Cologne, Cologne, Germany.ORCID https://orcid.org/0009-0008-5847-7086
Maike G SweegersNetherlands Cancer Institute, Amsterdam, the Netherlands.ORCID https://orcid.org/0000-0003-4892-4061
Mark TrevaskisMary MacKillop Institute for Health Research, Australian Catholic University, Melbourne, Australia.ORCID https://orcid.org/0000-0002-9078-0180
Helene RundqvistKarolinska Institutet, Stockholm, Sweden.ORCID https://orcid.org/0000-0002-5617-9076
Jana MüllerWorking Group Exercise Oncology, Division of Medical Oncology, National Center for Tumor Diseases (NCT) and Heidelberg University Hospital, Heidelberg, Germany.ORCID https://orcid.org/0000-0002-1718-1392
Joachim WiskemannWorking Group Exercise Oncology, Division of Medical Oncology, National Center for Tumor Diseases (NCT) and Heidelberg University Hospital, Heidelberg, Germany.ORCID https://orcid.org/0000-0002-5971-5436
Elsken van der WallJulius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht University, Utrecht, the Netherlands.
Neil K AaronsonNetherlands Cancer Institute, Amsterdam, the Netherlands.
Milena LachowiczMedical University of Gdańsk, Gdańsk, Poland.ORCID https://orcid.org/0000-0002-8402-0564
Ander UrruticoecheaGipuzkoa Cancer Unit, OSID-Onkologikoa, BioGipuzkoa, Osakidetza, San Sebastian, Spain.ORCID https://orcid.org/0000-0003-0359-3641
Eva M ZopfMary MacKillop Institute for Health Research, Australian Catholic University, Melbourne, Australia.ORCID https://orcid.org/0000-0001-6250-0041
Wilhelm BlochGerman Sport University Cologne, Cologne, Germany.
Martijn M StuiverNetherlands Cancer Institute, Amsterdam, the Netherlands.ORCID https://orcid.org/0000-0002-7794-7767
Yvonne WengströmKarolinska Institutet, Stockholm, Sweden.ORCID https://orcid.org/0000-0001-8317-7829
Anne M MayJulius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht University, Utrecht, the Netherlands.ORCID https://orcid.org/0000-0003-0643-3790
Karen SteindorfGerman Cancer Research Center (DKFZ) and National Center for Tumor Diseases (NCT) Heidelberg (a Partnership Between DKFZ and University Medical Center Heidelberg), Heidelberg, Germany.ORCID https://orcid.org/0000-0001-5215-5651

Funding

European Union's Horizon 2020 research and innovation program 825677National Health and Medical Research Council of Australia 2018/GNT1170698
6 · The paper itself

Abstract

purposeAs survival of patients with metastatic breast cancer (MBC) improves, their work situation is gaining importance. The aim of the current study was to identify factors associated with work status and quality of working life (QWL) in patients with MBC. Additionally, we investigated the effects of an exercise intervention on work status.

methodsWithin the multinational PREFERABLE-EFFECT exercise trial, 287 patients with MBC of working age (18-65 years) reported on their working situation over 9 months as a secondary endpoint. Among a subgroup of participants, QWL was assessed by the Quality of Working Life Questionnaire for Cancer Survivors (QWLQ-CS) (N = 59).

resultsAt baseline, 157 (54.7%) participants were employed, of whom one-third reported having recently reduced their amount of work because of fatigue (41.7%), cognitive problems (33.3%), or inability to meet work demands (33.3%). Participants wished for more flexible working hours (29.2%) and less productivity pressure (37.5%). Participants were less likely to work if they experienced higher levels of pain (p = 0.014). Among working participants, an academic education and higher levels of psychological distress were associated with a higher number of working hours (all p < 0.05). Fatigue, an academic education, and performing mentally strenuous tasks at work were negatively associated with QWL (all p < 0.05). The exercise intervention did not affect the number of hours worked during the study.

conclusionsSymptom management might be important for patients' ability to work. To help patients stay employed and improve QWL, employers should consider offering more flexible work arrangements and adapting to their employees' changing needs and abilities.

trial registrationThe PREFERABLE-EFFECT trial was registered with ClinicalTrials.gov on October 9, 2019 (NCT04120298).

Indexed as

Breast NeoplasmsEmploymentQuality of LifeAdolescentAdultAgedCancer SurvivorsExercise TherapyFatigueFemaleHumansMiddle AgedSurveys and QuestionnairesYoung Adultemploymentexercisefatiguemetastatic breast cancerpainquality of working life

Identifiers

PMID40714912
PMCPMC12296696

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.